Innovative research to improve understanding and treatment of endometrial cancer.
Official title: Developmental Research Program
Funded at Washington University · NIH-10912628 · Data updated 2026-11-12
This study is all about helping new researchers explore different ways to understand and treat endometrial cancer, especially by bringing in more diverse voices and ideas, so that we can find better solutions for everyone affected by this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 23, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $154,872 |
| NIH project number | 5P50CA265793-02 |
| Project ID | NIH-10912628 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals diagnosed with endometrial cancer or those at high risk for developing it.
✕Less likely to help
Patients with cancers other than endometrial cancer may not receive direct benefits from this research.
What this research studies
This program aims to support early-stage research focused on endometrial cancer, fostering innovative pilot projects that can evolve into larger studies. It seeks to increase the number of researchers dedicated to this area, particularly from underrepresented backgrounds, and to enhance diversity within the workforce. The program will provide funding for projects that span basic, translational, clinical, epidemiological, and cancer prevention research. Collaborations among institutions are encouraged to maximize the impact of the research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients with endometrial cancer.
How similar studies have gone: Previous research initiatives focused on endometrial cancer have shown promise, indicating that this approach could yield valuable insights.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Leslie, Kimberly K. — Washington University
- Study coordinator: Leslie, Kimberly K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.